×

Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine

  • US 9,498,476 B2
  • Filed: 08/31/2015
  • Issued: 11/22/2016
  • Est. Priority Date: 06/04/2008
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating depression in a mammal in need thereof comprising administering to the mammal a therapeutically-effective amount of Form N-1 of

View all claims
  • 5 Assignments
Timeline View
Assignment View
    ×
    ×